MEP Group

Acquired By Wise Equity
Ready-to-administer injectable pharmaceuticals are developed, produced, and distributed.

About MEP Group

MEP Group is an Industrial Goods & Manufacturing company, and was acquired by Wise Equity in January 2024. Ready-to-administer injectable pharmaceuticals are developed, produced, and distributed. The company was acqui-hired. Its focus areas include Industrial Goods and Manufacturing and Manufacturing Services.

Company details

Injectable pharmaceuticals are manufactured in the healthcare sector, with a focus on ready-to-administer formats. High-quality medications, including naloxone hydrochloride and sodium heparin, are produced in pre-filled syringes to support efficient administration. Development and distribution processes are conducted under strict regulatory compliance and quality controls. Operations emphasize precision in formulation and packaging to meet clinical needs.

Key Metrics

Investors in MEP Group

MEP Group has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Legris and Wise Equity.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity funds are managed for Italian SMEs.
2000wisesgr.comMilan, Italy
Manufacturer of twin-screw extrusion and power supply systems
1986legris-industries.comBrussels, Belgium
Premium access

Investor details for MEP Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of MEP Group

2 dated milestones of MEP Group across 5 years, from founding to its latest funding, stage changes and deals.

  1. Exit Acquired by Legris.
  2. Exit Acquired by Wise Equity.

Web traffic of MEP Group

The website of MEP Group (mepgroup.com) receives about 6.4K visits a month.

  • Monthly visits
    6.4K

    ▼ 28.3% vs previous month

Similar websites

Websites whose visitors overlap most with MEP Group. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
mepsaws.it
100%
4.8K#3,529,881View details
paris-en.intermatconstruction.com
paris-en.intermatconstruction.com
61%
–
mep.com
mep.com
22%
–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MEP Group

Injectable pharmaceuticals are manufactured in the healthcare sector, with a focus on ready-to-administer formats. High-quality medications, including naloxone hydrochloride and sodium heparin, are produced in pre-filled syringes to support efficient administration. Development and distribution processes are conducted under strict regulatory compliance and quality controls. Operations emphasize precision in formulation and packaging to meet clinical needs.

MEP Group has 2 investors. Key investors include Legris, and Wise Equity.

Yes. MEP Group was acquired by Legris in June 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available